Skip to content
healthcare.dev

9 Southern Grass Pollen Mix

NDC 22840-0225, Poa pratensis, Festuca elatior, Dactylis glomerata, Lolium perenne, Agrositis alba, Anthoxanthum odoratum, and Phleum pratense, solution, from Greer Laboratories, Inc..

Product NDC
22840-0225
Status
Listed
Labeler
Greer Laboratories, Inc.
Dosage form
SOLUTION
Route
INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
Product type
STANDARDIZED ALLERGENIC
Marketing category
BLA
Application
BLA101837
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/22840-0225 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYNODON DACTYLON POLLEN11111.11111 [BAU]/mL
  • POA PRATENSIS POLLEN11111.11111 [BAU]/mL
  • AGROSTIS GIGANTEA POLLEN11111.11111 [BAU]/mL
  • LOLIUM PERENNE POLLEN11111.11111 [BAU]/mL
  • LOLIUM PRATENSE POLLEN11111.11111 [BAU]/mL
  • ANTHOXANTHUM ODORATUM POLLEN11111.11111 [BAU]/mL
  • DACTYLIS GLOMERATA POLLEN11111.11111 [BAU]/mL
  • PHLEUM PRATENSE POLLEN11111.11111 [BAU]/mL
  • SORGHUM HALEPENSE POLLEN11111.11111 [BAU]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]

Package NDCNDC-11Package
22840-0225-22284002250210 mL in 1 VIAL, MULTI-DOSE (22840-0225-2)
22840-0225-42284002250450 mL in 1 VIAL, MULTI-DOSE (22840-0225-4)
22840-0225-5228400225055 mL in 1 BOTTLE, DROPPER (22840-0225-5)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 22840-0225 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/22840-0225 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 22840-0225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.